RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Diluted EPS

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndDiluted EPS (USD)YoY (%)
Jun 30, 20259.5+37.43%
Jun 30, 20246.9+13.63%
Jun 30, 20236.1+14.91%
Jun 30, 20225.3+63.58%
Jun 30, 20213.2-24.12%
Jun 30, 20204.3+52.50%
Jun 30, 20192.8+27.85%
Jun 30, 20182.2-8.75%
Jun 30, 20172.4-3.61%
Jun 30, 20162.5+0.81%
Jun 30, 20152.5+3.35%
Jun 30, 20142.4+13.81%
Jun 30, 20132.1+22.81%
Jun 30, 20121.7+18.75%
Jun 30, 20111.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)